Mustang Bio Inc Stock News

City of Hope’s physician-scientists and basic scientists are using their expertise to attack the deadly coronavirus on multiple research fronts.

Our times are dark. In addition to the lives lost to the disease, we are experiencing a secondary wave of economic destruction leading to more misery and yes, more deaths. But let us not forget the bi

WORCESTER, Mass., May 12, 2020 -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs.

Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Digital Realty Trust, Pilgrims Pride and Terraform Power, on Tuesday. HIGH

WORCESTER, Mass., May 11, 2020 -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs.

Mustang Bio, Inc. (“Mustang”) (MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematolo

Mustang Bio Inc (NASDAQ:MBIO) was the target of a significant decline in short interest during the month of March. As of March 31st, there was short interest totalling 520,200 shares, a decline of 22.

If you own shares in Mustang Bio, Inc. (NASDAQ:MBIO) then it's worth thinking about how it contributes to the...

Renaissance Technologies LLC grew its position in Mustang Bio Inc (NASDAQ:MBIO) by 9.2% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 766,972 shares of the company�

NEW YORK, March 16, 2020 -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in.

Is now the right time to invest in stocks? It’s possible that even the most guru-like among Wall Street observers will find the question hard to answer. The markets have yo-yoed dramatically over th

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 11) Bicycle Therapeutics...

Mustang Bio, Inc. (“Mustang”) (MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematolo

NEW YORK, Jan. 22, 2020 -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell.